$0
Cue Health, maker of COVID-19 tests, completed its initial public offering at $16 per share, right in the middle of its pricing expectations. The IPO raised $200 million for the company and gives it a valuation of $2.3 billion.
HLTH will debut on the Nasdaq later today, but shares are available for limit orders on Robinhood and other platforms.
Our top picks for where to buy Cue Health stock
How to buy Cue Health stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – HLTH. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Cue Health stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Cue Health stock price (NASDAQ: HLTH)
Use our graph to track the performance of HLTH stocks over time.Cue Health shares at a glance
Latest market close | $0.00 |
---|---|
52-week range | $0.00 - $0.74 |
50-day moving average | $0.11 |
200-day moving average | $0.25 |
Wall St. target price | $0.50 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-2.13 |
Is it a good time to buy Cue Health stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cue Health price performance over time
Historical closes compared with the close of $0 from 2024-06-18
1 week (2024-07-15) | nan% |
---|---|
1 month (2024-06-22) | nan% |
3 months (2024-04-26) | -100.00% |
6 months (2024-01-26) | -100.00% |
1 year (2023-07-26) | -100.00% |
---|---|
2 years (2022-07-26) | -100.00% |
3 years (2021-07-22) | N/A |
5 years (2019-07-22) | N/A |
Cue Health financials
Revenue TTM | $56.2 million |
---|---|
Gross profit TTM | $-17,949,000 |
Return on assets TTM | -30.8% |
Return on equity TTM | -94.57% |
Profit margin | 0% |
Book value | $1.26 |
Market Capitalization | $6.9 million |
TTM: trailing 12 months
Cue Health share dividends
We're not expecting Cue Health to pay a dividend over the next 12 months.
You may also wish to consider:
- Quest Diagnostics Incorporated (DGX.US) (2.05% forward annual dividend yield)
Cue Health share price volatility
Over the last 12 months, Cue Health's shares have ranged in value from as little as $0.0036 up to $0.74. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cue Health's is 1.086. This would suggest that Cue Health's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
To put Cue Health's beta into context you can compare it against those of similar companies.
- Co-Diagnostics (CODX.US): -0.826
- Quest Diagnostics Incorporated (DGX.US): 0.881
- Hologic (HOLX.US): 0.989
Cue Health overview
Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, including integration with electronic medical record system, pharmacies and last-mile delivery, clinician networks, and laboratories. The company also provides COVID-19 testing kits. The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017.
Frequently asked questions
nullWhat percentage of Cue Health is owned by insiders or institutions?
Currently 11.565% of Cue Health shares are held by insiders and 52.807% by institutions. How many people work for Cue Health?
Latest data suggests 726 work at Cue Health. When does the fiscal year end for Cue Health?
Cue Health's fiscal year ends in December. Where is Cue Health based?
Cue Health's address is: 4980 Carroll Canyon Road, San Diego, CA, United States, 92121 What is Cue Health's ISIN number?
Cue Health's international securities identification number is: US2297901009
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
How to buy the new spot Ethereum ETFs
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 top semiconductor stocks to buy in 2024
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
-
11 best brokerage accounts of July 2024: Top picks for investors
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
Ask a question